Evaluating mentalization-based psychotherapy for anxiety and depression
Official title: Brief Mentalization-based Group Psychotherapy for Anxiety and Depression Disorders and Spanish Cultural Adaptation and Validation of the Epistemic Trust Questionnaire (QET)
Run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · NCT06833567 · Data updated 2026-11-12
This study is testing a new group therapy called mentalization-based psychotherapy to see if it helps people with anxiety and depression feel better compared to standard therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud Academic / other |
| Locations | 1 site (Málaga, Malaga) |
| Status | Recruiting |
| Started | April 28, 2024 |
| Main results expected | May 29, 2026 |
| Study ends | June 2026 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT06833567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a diagnosis of anxiety or depression who possess minimal relational skills for group therapy.
✕Probably not a fit
Patients with severe cognitive deficits, structured suicidal ideation, or certain other psychiatric diagnoses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of mentalization-based group psychotherapy on patients diagnosed with anxiety and/or depression. A total of 100 participants will be recruited from community mental health services and randomized into two groups: one receiving standard acceptance and commitment therapy and the other receiving the new mentalization-based intervention. Assessments will be conducted at baseline and after three months to measure various psychological outcomes. The study aims to ensure participant safety and data integrity throughout the trial.
Why it matters
Potential benefit: If successful, this approach could provide a new therapeutic option for patients struggling with anxiety and depression.
How similar studies have gone: While similar approaches have been explored, this specific mentalization-based intervention is relatively novel in the context of anxiety and depression treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants are 18 years or older. * Participants have a diagnosis of ICD-10 F32, F33, F34, F41.1, F41.2, F43 or F43.2. * Participants have minimal relational skills to participate in group therapy. * Participants agree to be part of the study by giving signed written consent. Exclusion Criteria: * Participants have a diagnosis of ICD-10 F10-19, F20-29, F31, F42, F43.1, F60. * Participants with cognitive deficits assessed during the initial interview or diagnosis of ICD-10 F70-79. * Participants with planning or structured suicidal ideation. * Participants with difficulties in relational skills evaluated during the initial interview.
Where it's running
-
Instituto de Investigacion Biomedica de Malaga - IBIMA
Málaga, Malaga, Spain Recruiting
Study contacts
- Study coordinator: Maria Traverso Rodriguez
- Email: mariatraverso8@gmail.com
- Phone: +34 660512210
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain stimulation for anxiety and depression in children and teens
This program will try transcranial magnetic stimulation (TMS) to see if it reduces anxiety and depression in children and teens aged 6 to 18 who are referred by their doctors.
-
Cognitive training for anxiety, depression, and PTSD
This study is testing a brain training program to see if it can help people with anxiety, depression, or PTSD think more clearly and feel better.
-
Investigating brain responses to threats in anxiety and depression
This study is testing how an anti-anxiety medication affects the brain's response to threats in people with anxiety, depression, or both to better understand their differences and improve treatments.
-
Using RxWell to Reduce Opioid Use After Knee or Hip Surgery
This study is testing whether a digital tool called RxWell can help people with mood disorders who are having knee or hip surgery reduce their opioid use and improve their mental health after the operation.
-
Exploring factors influencing anxiety and depression
This study looks at how different thoughts, feelings, biology, and social support affect anxiety and depression to help improve treatment for those struggling with these conditions.
-
Investigating brain response variability to predict success in online therapy for mental health
This study is testing if changes in brain activity can help predict how well online therapy works for people with depression, anxiety, and insomnia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.